257 related articles for article (PubMed ID: 32545619)
1. Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by
Ortiz-Guerrero G; Gonzalez-Reyes RE; de-la-Torre A; Medina-Rincón G; Nava-Mesa MO
Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32545619
[No Abstract] [Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii Infection Potentiates Cognitive Impairments of Alzheimer's Disease in the BALB/c Mice.
Mahmoudvand H; Sheibani V; Shojaee S; Mirbadie SR; Keshavarz H; Esmaeelpour K; Keyhani AR; Ziaali N
J Parasitol; 2016 Dec; 102(6):629-635. PubMed ID: 27513205
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
6. iTRAQ-based differential proteomic analysis in Mongolian gerbil brains chronically infected with Toxoplasma gondii.
Lv L; Wang Y; Feng W; Hernandez JA; Huang W; Zheng Y; Zhou X; Lv S; Chen Y; Yuan ZG
J Proteomics; 2017 May; 160():74-83. PubMed ID: 28323244
[TBL] [Abstract][Full Text] [Related]
7. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly.
Daulatzai MA
J Neurosci Res; 2015 Dec; 93(12):1778-94. PubMed ID: 26301370
[TBL] [Abstract][Full Text] [Related]
8. Neuronal impairment following chronic Toxoplasma gondii infection is aggravated by intestinal nematode challenge in an IFN-γ-dependent manner.
French T; Düsedau HP; Steffen J; Biswas A; Ahmed N; Hartmann S; Schüler T; Schott BH; Dunay IR
J Neuroinflammation; 2019 Jul; 16(1):159. PubMed ID: 31352901
[TBL] [Abstract][Full Text] [Related]
9. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
[TBL] [Abstract][Full Text] [Related]
10. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
11. Infectious agents and Alzheimer's disease.
Piekut T; Hurła M; Banaszek N; Szejn P; Dorszewska J; Kozubski W; Prendecki M
J Integr Neurosci; 2022 Mar; 21(2):73. PubMed ID: 35364661
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system.
Mendez OA; Koshy AA
PLoS Pathog; 2017 Jul; 13(7):e1006351. PubMed ID: 28727854
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
15. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
16. Is Toxoplasma gondii a potential risk factor for Alzheimer's disease? A systematic review and meta-analysis.
Nayeri Chegeni T; Sarvi S; Moosazadeh M; Sharif M; Aghayan SA; Amouei A; Hosseininejad Z; Daryani A
Microb Pathog; 2019 Dec; 137():103751. PubMed ID: 31536800
[TBL] [Abstract][Full Text] [Related]
17. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
18. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
20. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
